Skip to Main Content
TRC_Tech_Canada
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • New Drugs
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: We have made updates to the logos on our site. This will not impact access to your subscription.
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes

Diabetes

  • Diabetes (431)
    • Blood Glucose Meters (4)
    • Complications (102)
    • Diabetes in Pregnancy (4)
    • Diabetes Meds (61)
    • Drug-Induced Hypo/Hyperglycemia (97)
    • Monitoring (80)
    • Natural Medicines/Supplements (8)
    • Prevention (26)
    • Treatment (194)
  • Endocrinology (9)
  • Hyperglycemia (24)
  • Hypoglycemia (22)
  • Other (15)
  • Prediabetes (2)
  • Resources (129)
  • Thyroid Disorders (41)
316 - 330 of 431 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Other: Clinically Significant Drug-Induced Nutrient Depletion February 2008
Other: Colesevelam (WelChol) in the Treatment of Type 2 Diabetes February 2008
Commentary: Rx Essentials for Drug-Induced Nutrient Depletion February 2008
Other: Symlin (Pramlintide) Pen January 2008
Other: FDA Adds Boxed Warning for Heart-related Risks to Avandia December 2007
Guideline: Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012) November 2007
Other: Info for Healthcare Providers About the Discontinuation of Exubera November 2007
Commentary: Exubera Off the Market November 2007
Guideline: American Diabetes Association Position Statement - Standards of Medical Care in Diabetes - 2008 September 2007
Guideline: Canadian Diabetes Association Clinical Practice Guidelines on Monitoring Glycemic Control (2008) September 2007
Commentary: Avandia (Rosiglitazone) and the Risk of Myocardial Infarction July 2007
Guideline: Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012) July 2007
Chart: Avandia (rosiglitazone) and the risk of myocardial infarction June 2007
Other: New Insulin Premix Formulation: NovoMix 30 April 2007
Other: Glitazones and Increased Fracture Risk April 2007
  • « Prev
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved